The effect of losartan on endothelial function in patients with essential hypertension by measuring flow-mediated vasodilation
MA Yushan
Abstract
MA Yushan
Abstract
Objective: To investigate the effect of losartan on endothelial function in patients with essential hypertension by using flow-mediated vasodilation(FMD) of brachial artery. Methods: We tested the basic FMD and maximum velocity(Vmax) of brachial artery in 20 patients with essential hypertension. After giving the patients 50mg losartan per day for 8 weeks, the FMD and Vmax was tested again. The blood pressure (BP) was measured simultaneously. Results: After the treatment there were no significant changes of brachial artery initial diameter while FMD increased significantly (4. 64% ± 3. 72% vs 7. 68% ± 6. 12% , P = 0.024) and the change was independent of BP decreasing. The Vmax was also increased significantly. Conclusions: The brachial FMD can be regarded as a useful method to evaluate endothelial-dependent vasodilative function. Flow-mediated brachial artery dilation would be improved afer taking losartan 50mg/d for 8 weeks, and this is independent of BP decreasing.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of losartan on endothelial function in patients with essential hypertension by using flow-mediated vasodilation(FMD) of brachial artery. Methods: We tested the basic FMD and maximum velocity(Vmax) of brachial artery in 20 patients with essential hypertension. After giving the patients 50mg losartan per day for 8 weeks, the FMD and Vmax was tested again. The blood pressure (BP) was measured simultaneously. Results: After the treatment there were no significant changes of brachial artery initial diameter while FMD increased significantly (4. 64% ± 3. 72% vs 7. 68% ± 6. 12% , P = 0.024) and the change was independent of BP decreasing. The Vmax was also increased significantly. Conclusions: The brachial FMD can be regarded as a useful method to evaluate endothelial-dependent vasodilative function. Flow-mediated brachial artery dilation would be improved afer taking losartan 50mg/d for 8 weeks, and this is independent of BP decreasing.
Key concepts: Brachial artery, Losartan, Vasodilation, Medicine, Cardiology, Internal medicine, Essential hypertension, Blood pressure